Document:

Exhibit
4.4

 

WARRANT
AGENT AGREEMENT

 

WARRANT
AGENT AGREEMENT (this “Warrant Agreement”) dated as of ______, 2022 (the “Issuance Date”) between
TC BioPharm (Holdings) plc, a company incorporated in Scotland, under the law of the United Kingdom (the “Company”),
and Computershare Inc., a Delaware corporation (“Computershare”), and its wholly owned subsidiary, Computershare Trust
Company, N.A., a federally chartered trust company (the “Warrant Agent”).

 

WHEREAS,
pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), dated _______, 2022, between
the Company and EF Hutton, division of Benchmark Investments, LLC, as representative of the underwriters set forth therein, the Company
is engaged in a public offering (the “Offering”) of up to _________ American Depositary Shares (“ADSs”),
each ADS representing one ordinary share of the Company, par value £0.01 per share (“Ordinary Shares”), and
up to ________ Warrants (the “Warrants”), with each Warrant representing the right of the holder thereof to purchase
one ADS (each, a “Warrant ADS”) for $_____[NTD: 125% of IPO price] per ADS, subject to adjustment as
described herein, plus applicable fees, charges and taxes;

 

WHEREAS,
the ADSs are issuable under the Deposit Agreement dated as of January __, 2022 (the “Deposit Agreement”) among the
Company, The Bank of New York Mellon, as depositary (the “Depositary”), and all Owners and Holders (each as defined
in the Deposit Agreement) from time to time of the ADSs issued thereunder;

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form
F-1, File No. 333-260492 (as the same may be amended from time to time, the “Registration Statement”) for the registration,
under the Securities Act of 1933, as amended (the “Securities Act”), of, among other securities, the Ordinary Shares,
the Warrants and the Ordinary Shares underlying the Warrant ADSs issuable upon exercise of the Warrants (the “Warrant Shares”),
and the Registration Statement was declared effective on ________, 2022;

 

WHEREAS,
the Depositary has filed with the Commission a Registration Statement on Form F-6, File No. 333-______ (the “ADS Registration
Statement”) for the registration under the Securities Act of the ADSs that may be issued in exchange for Ordinary Shares and
the Warrant Shares, and the Registration Statement was declared effective on _____, 2022.

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with
the terms set forth in this Warrant Agreement in connection with the issuance, registration, registration of transfer and exercise of
the Warrants;

 

WHEREAS,
the Company desires to provide for the provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective
rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS,
the Company has duly authorized the execution and delivery of this Warrant Agreement and all other acts and things necessary to make
the Warrants the legal, valid and binding obligations of the Company have been done and performed.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby
appoints the Warrant Agent to act as agent for the Company with respect to the Warrants, and the Warrant Agent hereby accepts such appointment
and agrees to perform the same in accordance with the express terms and conditions set forth in this Warrant Agreement (and no implied
terms or conditions).

 

    	1

     

    

 

2.
Warrants.

 

2.1
Form of Warrants. The Warrants shall be registered securities in book entry form and shall be evidenced by a global certificate
(“Global Certificate”) in the form of Annex C to this Warrant Agreement, which shall be deposited on behalf
of the Company with a custodian for The Depository Trust Company (“DTC”) and registered in the name of Cede &
Co., as nominee of DTC. If DTC subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may
instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Warrants are not eligible
for, or it is no longer necessary to have the Warrants available in, book-entry form, the Company may instruct the Warrant Agent to provide
written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Certificate, and the Company shall instruct the
Warrant Agent to deliver each holder of the Warrants separate certificates in the form of Annex A evidencing Warrants (“Definitive
Certificates” and, together with the Global Certificate, “Warrant Certificates”) registered as requested
through the DTC system. In the event Definitive Certificates are delivered to the holders, the transfer, exchange or exercise of the
Warrants shall be conducted in accordance with the customary procedures of the Warrant Agent. The Company shall use its best efforts
to enable the Warrants be “DTC eligible” so that the interests in the Warrants may be held in book-entry through DTC for
the term of the Warrants.

 

2.1.1
Exchange of Interest in Global Certificate for Definitive Certificate. Notwithstanding Section 2.1 above, a holder of a security
entitlement in Warrants evidenced by the Global Certificate has the right to elect at any time to exchange it for a Definitive Certificate
evidencing the same number of Warrants. Upon written notice by a Participant having Warrants credited to its DTC account for the exchange
of some or all that entitlement for a Definitive Certificate evidencing the same number of Warrants, which request shall be in the form
attached hereto as Annex B (a “Warrant Certificate Request Notice” and the date of delivery of such Warrant
Certificate Request Notice by the Holder, the “Warrant Certificate Request Notice Date” and the exchange made pursuant
to the Warrant Certificate Request Notice, a “Warrant Exchange”), and upon surrender by that Participant of the Warrants
to be exchanged to the Warrant Agent through DTC’s system, the Warrant Agent shall, without unreasonable delay, effect the Warrant
Exchange by issuing and delivering a Definitive Certificate for such number of Warrants in the name and mailed to the address set forth
in the Warrant Certificate Request Notice. Such Definitive Certificate shall be dated the original issue date of the Warrants, shall
be manually executed by an authorized signatory of the Company and shall be in the form attached hereto as Annex A In connection
with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant Agent to deliver, the Definitive Certificate to the
specified holder within ten (10) Business Days of the Warrant Certificate Request Notice pursuant to the delivery instructions in the
Warrant Certificate Request Notice (the “Warrant Certificate Delivery Date”). “Business Day” means
any day other than a Saturday, Sunday, or a day on which banking institutions in the State of New York are authorized or obligated by
law or executive order to close; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.

 

2.1.2
The Company shall provide to the Warrant Agent an opinion of counsel on or prior to the issuance of Warrants to set up a reserve of Warrant
Shares for the outstanding Warrants. The opinion shall state that all Warrants or Warrant Shares, as applicable, are (i) registered under
the Securities Act of 1933, as amended, and (ii) validly issued, fully paid and non-assessable.

 

2.2
Issuance and Registration of Warrants.

 

2.2.1
Warrant Register. Upon the receipt of all relevant information from the Company or its agents, the Warrant Agent shall maintain
books (“Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants.

 

    	2

     

    

 

2.2.2
Issuance of Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue the Global Certificate and deliver
the Warrants in the DTC book-entry settlement system in accordance with written instructions delivered to the Warrant Agent by the Company.
Ownership of beneficial interests in the Warrants shall be shown on, and the transfer of such ownership shall be effected through, records
maintained (i) by DTC and (ii) by institutions that have accounts with DTC (each, with respect to a Warrant in its account, a “Participant”).

 

2.2.3
Beneficial Owner; Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name that Warrant shall be registered on the Warrant Register (the “Holder”,
which shall include, if the Warrants are held in “street name,” a Participant or a designee appointed by such Participant)
as the absolute owner of such Warrant for purposes of any exercise thereof, and for all other purposes, and neither the Company nor the
Warrant Agent shall be affected by any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the Company,
the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or other authorization
furnished by DTC governing the exercise of the rights of a holder of a beneficial interest in any Warrant. The rights of beneficial owners
in a Warrant evidenced by the Global Certificate shall be exercised by the Holder through the DTC system.

 

2.2.4
Execution. The Warrant Certificates shall be executed on behalf of the Company by any authorized officer of the Company (an “Authorized
Officer”), which need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile
signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent either by manual, electronic
or facsimile signature, which need not be the same signatory for all of the Warrant Certificates, and no Warrant Certificate shall be
valid for any purpose unless so countersigned. In case any Authorized Officer of the Company that signed any of the Warrant Certificates
ceases to be an Authorized Officer of the Company before countersignature by the Warrant Agent and issuance and delivery by the Company,
such Warrant Certificates, nevertheless, may be countersigned by the Warrant Agent, issued and delivered with the same force and effect
as though the person who signed such Warrant Certificates had not ceased to be such officer of the Company; and any Warrant Certificate
may be signed on behalf of the Company by any person who, at the actual date of the execution of such Warrant Certificate, shall be an
Authorized Officer of the Company authorized to sign such Warrant Certificate, although at the date of the execution of this Warrant
Agreement any such person was not such an Authorized Officer. The rights of holders of Warrant Certificates shall be identical regardless
of the Authorized Officer signing for and on behalf of the Company and of the authorized signatory of the Warrant Agent signing such
certificates.

 

2.2.5
Registration of Transfer. At any time at or prior to the Expiration Date (as defined below), a transfer of any Warrants may be
registered and any Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate
or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or Warrant Certificates surrendered. Any Holder
desiring to register the transfer of Warrants or to split up, combine or exchange any Warrant Certificate shall make such request in
writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates evidencing
the Warrants the transfer of which is to be registered or that is or are to be split up, combined or exchanged and, in the case of registration
of transfer, shall provide a signature guarantee by an “eligible guarantor institution” that is a member or participant in
the Securities Transfer Agents Medallion Program or other comparable “signature guarantee program.” Thereupon, the Warrant
Agent shall countersign and deliver to the person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be,
as so requested. The Company and the Warrant Agent may require payment by the Holder requesting a registration of transfer of Warrants
or a split-up, combination or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Warrants
and issuance of Warrant ADS to the Holder) of a sum sufficient to cover any tax or governmental charge that may be imposed in connection
with such registration of transfer, split-up, combination or exchange, together with reimbursement to the Company and the Warrant Agent
of all reasonable expenses incidental thereto. The Warrant Agent shall not have any duty or obligation to take any action under any section
of this Warrant Agreement that requires the payment of taxes and/or charges unless and until it is satisfied that all such payments have
been made.

 

    	3

     

    

 

2.2.6
Loss, Theft and Mutilation of Warrant Certificates. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security acceptable to the Warrant Agent, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates.
The Warrant Agent may receive compensation from the surety companies or surety agents for administrative services provided to them. Notwithstanding
anything herein to the contrary, in connection with a Warrant in book-entry form through DTC, no posting of a bond shall be required
under this Section 2.2.6.

 

2.2.7
Proxies. The Holder of a Warrant may grant proxies or otherwise authorize any person, including Participants and beneficial holders
that may own interests through Participants, to take any action that a Holder is entitled to take under this Warrant Agreement or the
Warrants; provided, however, that at all times that Warrants are evidenced by a Global Certificate, exercise of those Warrants
shall be effected on their behalf by Participants through DTC in accordance with the procedures administered by DTC.

 

3.
Terms and Exercise of Warrants.

 

3.1
Exercise Price. Each Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate and of
this Warrant Agreement, to purchase from the Company the number of ADSs stated therein, at the price of US$______[NTD: 125% of
IPO share price] per ADS, subject to the subsequent adjustments provided in Section 4 hereof. The term “Exercise Price”
as used in this Warrant Agreement refers to the price per ADS at which ADSs may be purchased at the time a Warrant is exercised.

 

3.2
Duration of Warrants. Warrants may be exercised only during the period (“Exercise Period”) commencing on the
Issuance Date and terminating at 5:00 P.M., New York City time (the “close of business”) on _________, 2025 [NTD:
Three years after IPO effective date] (“Expiration Date”). Each Warrant not exercised on or before the Expiration
Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement shall cease at the close
of business on the Expiration Date.

 

3.3
Exercise of Warrants.

 

3.3.1
Exercise and Payment. (a) Subject to the provisions of this Warrant Agreement, a Holder (or a Participant acting on behalf of
a Holder in accordance with DTC procedures) may exercise Warrants by delivering to the Warrant Agent, not later than 5:00 P.M., New York
City time, on any Business Day during the Exercise Period an election to purchase the Warrant ADSs to be exercised (A) in the form included
in Exhibit A to the Warrant or (B) via an electronic warrant exercise through the DTC system (each, an “Election to Purchase”).
Within one Trading Day following the delivery of the Election to Purchase, the Holder shall deliver (i) the Warrants to be exercised
by (A) surrender of the Warrant Certificate evidencing the Warrants to the Warrant Agent at its office designated for such purpose or
(B) delivery of the Warrants to an account of the Warrant Agent at DTC designated for such purpose in writing by the Warrant Agent to
DTC from time to time, and (ii) the Exercise Price for each Warrant to be exercised (and, if applicable, any taxes or charges due in
connection with the exercise of such Warrants), in lawful money of the United States of America by (A) certified or official bank check
or wire transfer from a United States bank payable to the Warrant Agent or (B) payment to the Warrant Agent through the DTC system.

 

(b)
If any of (i) the Warrants, (ii) the Election to Purchase, or (iii) the Exercise Price therefor (and, if applicable, any taxes or charges
due in connection with the exercise of such Warrants), is received by the Warrant Agent on any date after 5:00 P.M., New York City time,
or on a date that is not a Trading Day, the Warrants with respect thereto will be deemed to have been received and exercised on the Trading
Day next succeeding such date. The “Exercise Date” will be the date on which the Election to Purchase is delivered
to the Warrant Agent; however, the Warrants shall not be deemed to be exercised if the Warrants and the Exercise Price therefor are not
received by the Warrant Agent on or prior to the Trading Day following the delivery of the Election to Purchase. If the Warrants are
received or deemed to be received after the Expiration Date, the exercise thereof will be null and void and any funds delivered to the
Warrant Agent will be returned to the Holder or Participant, as the case may be, as soon as practicable. “Trading Day”
means any day on which the ADSs are traded on the Trading Market, or, if the Trading Market is not the principal trading market for the
ADSs, then on the principal securities exchange or securities market in the United States on which the ADSs are then traded. “Trading
Market” means NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New
York Stock Exchange.

 

    	4

     

    

 

(c)
The Warrant Agent shall deposit all funds received by it in payment of the Exercise Price in the account maintained by the Warrant Agent
in its name as agent for the Company. The Warrant Agent shall remit to the Company funds received for warrant exercises in a given month
by the fifth Business Day of the following month by wire transfer to an account designated by the Company, or as otherwise from time
to time as reasonably requested by the Company. All funds received by Computershare under this Agreement that are to be distributed or
applied by Computershare in the performance of services hereunder (the “Funds”) shall be held by Computershare as agent for
the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company. Until
paid pursuant to the terms of this Warrant Agreement, Computershare will hold the Funds in deposit accounts with U.S. commercial banks
with Tier 1 capital exceeding $1 billion or with ratings above investment grade by S&P Global Ratings (LT Local Issuer Credit Rating),
Moody’s Investors Service (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg
L.P.). Computershare shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made
by Computershare in accordance with this Section 3.3.1(c), including any losses resulting from a default by any bank, financial institution
or other third party. Computershare may from time to time receive interest, dividends or other earnings in connection with such deposits.
Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party.

 

(d)
If less than all the Warrants evidenced by a surrendered Warrant Certificate are exercised, the Warrant Agent shall split up the surrendered
Warrant Certificate and return to the Holder a Warrant Certificate evidencing the Warrants that were not exercised.

 

3.3.2
Issuance of Warrant Shares. (a) The Warrant Agent shall, by 11:00 a.m., New York City time, on the Trading Day following the Exercise
Date of any Warrant, advise the Company, the transfer agent and registrar for Ordinary Shares and the Depositary, in respect of (i) the
number of Warrant Shares indicated on the Election to Purchase as issuable upon such exercise with respect to such exercised Warrants,
(ii) the instructions of the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of
the Warrant ADSs and the number of Warrants that remain outstanding after such exercise and (iii) such other information as the Company
or the Depositary shall reasonably request.

 

(b)
The Company shall, by no later than 5:00 P.M., New York City time, on the fourth Trading Day following the Exercise Date of any Warrant,
provided the funds in payment of the Exercise Price for each Warrant to be exercised have cleared on the Trading Day following the Exercise
Date, cause its registrar to deliver the Warrant Shares issuable upon that exercise to the Depositary’s custodian for deposit under
the Deposit Agreement and instruct the Depositary to deliver the Warrant ADSs issuable upon that deposit of Warrant Shares as requested
in the Election to Purchase.

 

(c)
The Company shall, by no later than 5:00 P.M., New York City time, on the fifth Trading Day following the Exercise Date of any Warrant,
provided the funds in payment of the Exercise Price for each Warrant to be exercised have cleared on the Trading Day following the Exercise
Date, cause the Depositary to deliver the Warrant ADSs to the Holder pursuant to the Election to Purchase (the “Warrant ADS
Delivery Date”).

 

3.3.3
Valid Issuance. All Warrant Shares and Warrant ADSs issuable by the Company upon the proper exercise of a Warrant in conformity
with this Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

3.3.4
No Fractional Exercise. No fractional Warrant ADSs will be issued upon the exercise of the Warrant, but rather the Company shall
adjust the number of Warrant Shares issued up or down to the nearest integral multiple of the number of Ordinary Shares at the time represented
by one ADS.

 

    	5

     

    

 

3.3.5
No Transfer Taxes. The Company shall not be required to pay any stamp or other tax or charge required to be paid in connection
with the exercise of Warrants; and the Company shall not be required to issue or deliver any Warrant ADSs until such tax or other charge
shall have been paid or it has been established to the satisfaction of the Company and the Warrant Agent that no such tax or other charge
is due. For purposes of clarity, the Company shall pay any stamp or other tax or charge required to be paid in connection with any issuance
to the Holder of the Warrant ADSs upon the exercise of Warrants.

 

3.3.6
Date of Issuance. (a) The Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
ADSs only on the Warrant ADS Delivery Date, except that, if the Exercise Date is a date when the stock transfer books of the Company
are closed, such person shall be deemed to have become the holder of such shares at the open of business on the next succeeding date
on which the stock transfer books are open; provided, however, Warrant ADSs will not be registered or issued until the Depositary receives
notice from its custodian that the Warrant Shares have been deposited under the Deposit Agreement; provided further, however, that the
Company shall take all reasonable steps to ensure the Warrant ADSs are delivered to the Holder on or prior to the Warrant ADS Delivery
Date in accordance with Section 3.3.2(c) hereof and, if the Warrant ADSs are not delivered to the Holder on or prior to the Warrant ADS
Delivery Date, the provisions of Section 3.3.9 shall apply.

 

(b)
No exercising Holder, which Holder effected a Warrant Exchange pursuant to Section 2.1.1 prior to the Exercise Date, shall be required
to surrender its Warrant to the Warrant Agent, unless such exercise is for the remaining numbers of ADSs issuable upon exercise of such
Warrant, in which case the Holder shall deliver the Warrant Certificate to the Warrant Agent within three (3) Business Days.

 

3.3.7
Restrictive Legend Events. The Company shall use its commercially reasonable efforts to maintain the effectiveness of the Registration
Statement and the ADS Registration Statement and the current status of the prospectuses included therein or to file and maintain the
effectiveness of another registration statement and another current prospectus covering the Warrants and the Warrant Shares at any time
that the Warrants are exercisable. The Company shall provide to the Warrant Agent and each Holder prompt written notice of any time that
the Company is unable to deliver the Warrant ADSs via DTC transfer or otherwise without restrictive legend because (A) the Commission
has issued a stop order with respect to the Registration Statement or the ADS Registration Statement, (B) the Commission otherwise has
suspended or withdrawn the effectiveness of the Registration Statement or the ADS Registration Statement, either temporarily or permanently,
(C) the Company has suspended or withdrawn the effectiveness of the Registration Statement or the ADS Registration Statement, either
temporarily or permanently, (D) the prospectuses contained in the Registration Statement and the ADS Registration Statement are not available
for the issuance of the Warrant ADSs to the Holder, (E) the Registration Statement or the ADS Registration Statement or the prospectuses
contained therein are not current and do not conform to the requirements of the applicable rules and regulations, or the SEC has not
declared effective a post-effective amendment to the Registration Statement or the ADS Registration Statement if one is required to be
filed to update the disclosures therein, or (F) otherwise (each a “Restrictive Legend Event”). To the extent that
the Warrants cannot be exercised as a result of a Restrictive Legend Event or a Restrictive Legend Event occurs after a Holder has exercised
Warrants in accordance with the terms of the Warrants but prior to the delivery of the Warrant ADSs, the Company shall, at the election
of the Holder, which shall be given within five (5) days of receipt of such notice of the Restrictive Legend Event, either rescind the
previously submitted Election to Purchase and the Company shall return all consideration paid by registered holder for such shares upon
such.

 

3.3.8
Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of
Warrant ADSs issuable in connection with any exercise, the Company shall promptly deliver to the Holder the number of Warrant ADSs that
are not disputed.

 

    	6

     

    

 

3.3.9
Compensation for Buy-In on Failure to Timely Deliver Warrant ADSs Upon Exercise. In addition to any other rights available to
the Holder, if the Company fails to cause the Depositary to deliver the Warrant ADSs to the Holder pursuant to Section 3.3.2, and if
after such date the beneficial owner is required by its broker to purchase (in an open market transaction or otherwise) or the beneficial
owner’s brokerage firm otherwise purchases, ADSs or Ordinary Shares to deliver in satisfaction of a sale by the beneficial owner
of the Warrant ADSs, which the beneficial owner anticipated receiving upon such exercise (a “Buy-In”), then the Company
shall (A) pay in cash to the Holder the amount, if any, by which (x) the beneficial owner’s total purchase price (including brokerage
commissions, if any) for the Warrant ADSs or Warrant Shares so purchased exceeds (y) the amount obtained by multiplying (i) the number
of Warrant ADSs or Warrant Shares, as applicable, that the Company was required to deliver to the Holder in connection with the exercise
at issue times (ii) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of
the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant ADSs or Warrant Shares, as applicable, for which
such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Warrant
ADSs or Warrant Shares, as applicable, that would have been issued had the Company timely complied with its delivery obligations. For
example, if the beneficial owner purchases ADSs or Ordinary Shares having a total purchase price (including brokerage commissions) of
$11,000 to cover a Buy-In with respect to an attempted exercise of Warrant ADSs with an aggregate sale price giving rise to such purchase
obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000
for the benefit of the beneficial owner. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit right of a
Holder to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company’s failure to timely deliver Warrant ADSs upon exercise of Warrants
as required pursuant to the terms of this Warrant Agreement. The Warrant Agent shall have no liability for the Company’s failure
to deliver to the Holders the Warrant ADSs as set forth in this Section 3.3.9.

 

In
addition, if the Company fails for any reason to deliver to the Holder the Warrant ADSs subject to an Election to Purchase by the Warrant
ADS Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
ADSs subject to such exercise (based on the VWAP of the ADSs on the date of the applicable Election to Purchase), $10 per Trading Day
for each Trading Day after such Warrant ADS Delivery Date until such Warrant ADSs are delivered or Holder rescinds such exercise. The
Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and
exercisable. In addition, if the Company fails to cause the Depository to transmit to the Holder the Warrant ADSs by the Warrant ADS
Delivery Date, then the Holder will have the right to rescind such exercise.

 

For
purposes of this Warrant Agreement the term “VWAP” shall mean, for any date, the price determined by the first of
the following clauses that applies: (a) if the ADSs are then listed or quoted on a Trading Market, the daily volume weighted average
price of the ADSs for such date (or the nearest preceding date) on the Trading Market on which the ADSs are then listed or quoted as
reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) the volume
weighted average price of the ADSs for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the ADSs are not then
listed or quoted for trading on the OTC Bulletin Board and if prices for the ADSs are then reported in the OTCQB maintained by OTC Markets
Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent Bid Price per ADS
so reported, or (d) in all other cases, the fair market value of an ADS as determined by an independent appraiser selected in good faith
by the Company, the fees and expenses of which shall be paid by the Company.

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then
listed or quoted on a Trading Market, the Bid Price of the ADSs for the time in question (or the nearest preceding date) on the Trading
Market on which the ADSs is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the ADSs
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the ADSs are not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the ADSs are then reported on the Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent Bid Price per share of the ADSs so reported, or (d) in all other cases, the fair
market value of an ADS as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    	7

     

    

 

3.3.10
The Company shall pay all Warrant Agent and Depositary fees required for timely processing of any Election to Purchase and all fees to
DTC (or another established clearing corporation performing similar functions) required for electronic issuance and delivery of the Warrant
ADSs for timely delivery of Warrant ADSs on or prior to the Warrant ADSs Delivery Date. The Company shall pay all applicable fees and
expenses of the Depositary in connection with the issuance of the Warrants ADSs hereunder.

 

4.
Adjustments.

 

4.1
Adjustment upon Subdivisions or Combinations. If the Company at any time after the Issuance Date subdivides (by any stock split,
stock dividend, recapitalization, reorganization, scheme of arrangement or otherwise) its outstanding Ordinary Shares into a greater
number of Ordinary Shares or the ratio of Ordinary Shares per ADS is reduced (e.g., the ratio is changed from one Ordinary Share per
one ADS to two Ordinary Shares per one ADS), the Exercise Price in effect immediately prior to such subdivision will be proportionately
reduced and the number of Warrant ADSs will be proportionately increased. If the Company at any time after the Issuance Date combines
(by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) its outstanding Ordinary Shares
into a smaller number of Ordinary Shares or the ratio of Ordinary Shares per ADS is increased (e.g., the ratio is changed from one Ordinary
Shares per one ADS to three Ordinary Shares per one ADS), the Exercise Price in effect immediately prior to such combination will be
proportionately increased and the number of Warrant ADSs will be proportionately decreased. Any adjustment under this Section 4.1 shall
become effective at the close of business on the date the subdivision or combination or ratio change becomes effective. The Company shall
promptly notify the Warrant Agent in writing of any adjustment to the Warrants and give specific instructions to the Warrant Agent with
respect to any adjustments to the warrant register.

 

4.2
Adjustment for Other Distributions. In the event the Company shall fix a record date for the making of a dividend or distribution
to all holders of Ordinary Shares of any evidences of indebtedness or assets or subscription rights, options or warrants (excluding those
referred to in Section 4.1 or other dividends paid out of retained earnings), then in each such case the Holder will, upon the exercise
of Warrants, be entitled to receive, in addition to the number of Warrant ADSs issuable thereupon, and without payment of any additional
consideration therefor, the amount of such dividend or distribution, as applicable, which such Holder would have held on the date of
such exercise had such Holder been the holder of record of such Warrant ADSs as of the date on which holders of ADSs became entitled
to receive such dividend or distribution. Such adjustment shall be made whenever any such distribution is made and shall become effective
immediately after the record date mentioned above.

 

4.3
Reclassification, Consolidation, Purchase, Combination, Sale or Conveyance. If, at any time while the Warrants are outstanding,

 

	 	(i)	the
    Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
    another person;
	 	(ii)	the
    Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
    substantially all of its assets in one or a series of related transactions;
	 	(iii)	any
    direct or indirect purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant
    to which holders of ordinary shares (including those represented by ADSs) are permitted to sell, tender or exchange their shares
    for other securities, cash or property and has been accepted by the holders of 50% or more of the total voting power of the Company’s
    ordinary shares (including those represented by ADSs) (not including any Ordinary Shares (including those represented by ADSs) held
    by the other person or other persons making or party to, or associated or affiliated with the other persons making, such purchase
    offer, tender offer or exchange offer); 
	 	(iv)	the
    Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
    of ADSs or Ordinary Shares or any compulsory share exchange pursuant to which the ADSs or Ordinary Shares are effectively converted
    into or exchanged for other securities, cash or property, or 
	 	(v)	the
    Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
    combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person
    whereby such other person acquires more than 50% of the total voting power of the Company’s ordinary shares (including those
    represented by ADSs) (not including any Ordinary Shares (including those represented by ADSs) held by the other person or other persons
    making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement
    or other business combination) (each a “Fundamental Transaction”), 

 

    	8

     

    

 

then,
upon any subsequent exercise of a Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares, if any, of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, or depositary shares representing those shares, and any
additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by
a holder of the number of ADSs for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one ADS in such Fundamental Transaction and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of ADSs are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction.

 

The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor
Entity”), to assume in writing all of the obligations of the Company under this Warrant Agreement in accordance with the provisions
of this Section 4.3 pursuant to written agreements in form reasonably satisfactory to the Warrant Agent and shall, upon the written request
of the Holder of Warrants, deliver to that Holder in exchange for those Warrants a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to those Warrants that is exercisable for a corresponding number of shares of
capital stock of such Successor Entity (or its parent entity), if any, plus any Alternate Consideration, receivable as a result of such
Fundamental Transaction by a holder of the number of ADSs for which those Warrants were exercisable immediately prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock, if any, plus any
Alternate Consideration (but taking into account the relative value of the ADSs or Ordinary Shares prior to such Fundamental Transaction
and the value of such shares of capital stock plus Alternate Consideration after that Fundamental Transaction, for the purpose of protecting
the economic value those Warrants had immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of
any such Fundamental Transaction the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Warrant Agreement and the Warrant referring to the “Company” shall refer
instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the
Company under this Warrant Agreement and the Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

The
Company shall instruct the Warrant Agent in writing to mail, by first class mail, postage prepaid, to each Holder, written notice of
the execution of any such amendment, supplement or agreement with the Successor Entity. Any supplemented or amended agreement entered
into by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent as may be practicable
to the adjustments provided for in this Section 4.3. The Warrant Agent shall have no duty, responsibility or obligation to determine
the correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions relating either
to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method employed and
provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained in any
such agreement. The provisions of this Section 4.3 shall similarly apply to successive reclassifications, changes, consolidations, mergers,
sales and conveyances of the kind described above.

 

4.4
Other Events. If any event occurs of the type contemplated by the provisions of Section 4.1 or 4.2 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights
with equity features to all holders of ADSs for no consideration), then the Company’s board of directors will, at its discretion
and in good faith, make an adjustment in the Exercise Price and the number of Warrant ADSs or designate such additional consideration
to be deemed issuable upon exercise of a Warrant, so as to protect the rights of the registered Holder. No adjustment to the Exercise
Price will be made pursuant to more than one sub-section of this Section 4 in connection with a single issuance.

 

    	9

     

    

 

4.5
Notices of Changes in Warrant. Upon every adjustment of the Exercise Price or the number of Warrant ADSs issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise Price resulting
from such adjustment and the increase or decrease, if any, in the number of Warrant ADSs purchasable at such price upon the exercise
of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the
occurrence of any event specified in Sections 4.1 or 4.2, then, in any such event, the Company shall give written notice to each Holder,
at the last address set forth for such holder in the Warrant Register, as of the record date or the effective date of the event. Failure
to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant Agent shall be entitled
to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions provided by the Company
with respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Warrant, or any related matter,
and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with any such certificate,
notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be deemed to have knowledge of any such adjustment
unless and until it shall have received written notice thereof from the Company.

 

5.
Restrictive Legends; Fractional Warrants.

 

In
the event that a Warrant Certificate surrendered for transfer bears a restrictive legend, the Warrant Agent shall not register that transfer
until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether
the Warrants must also bear a restrictive legend upon that transfer. The Warrant Agent shall not be required to effect any registration
of transfer or exchange which will result in the transfer of or delivery of a Warrant Certificate for a fraction of a Warrant.

 

6.
Expense Reimbursement.

 

The
Company shall reimburse the Holder, upon the Holder’s request, for any reasonable fees charged to the Holder by the Depositary
in connection with the issuance or holding or sale of ADSs, Warrant ADSs and/or Ordinary Shares.

 

7.
Other Provisions Relating to Rights of Holders of
Warrants.

 

7.1
No Rights as Stockholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered holder of
Warrants, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice
of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance
to the Holder of the Warrant ADSs which it is then entitled to receive upon the due exercise of Warrants.

 

7.2
Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued
Ordinary Shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant Agreement
and which are available to be issued for that purpose without restriction (including without prejudice to the generality) by restriction
of pre-emption or offer round or other consent rights).

 

    	10

     

    

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1
(a) Whether or not any Warrants are exercised, the Company agrees to pay to the Warrant Agent reasonable compensation for all services
rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon and, from time to time, on demand of the Warrant
Agent , to reimburse the Warrant Agent for all of its reasonable expenses and counsel fees and other disbursements incurred in the preparation,
delivery, negotiation, amendment, administration and execution of this Warrant Agreement and the exercise and performance of its duties
hereunder.

 

(b)
All amounts owed by the Company to the Warrant Agent under this Warrant Agreement are due within 30 days of the invoice date. Delinquent
payments are subject to a late payment charge of one and one-half percent (1.5%) per month commencing 45 days from the invoice date.
The Company agrees to reimburse the Warrant Agent for any attorney’s fees and any other costs associated with collecting delinquent
payments.

 

(c)
No provision of this Warrant Agreement shall require Warrant Agent to expend or risk its own funds or otherwise incur any financial liability
in the performance of any of its duties under this Warrant Agreement or in the exercise of its rights.

 

8.2
As agent for the Company hereunder the Warrant Agent:

 

(a)
shall have no duties or obligations other than those specifically set forth in this Warrant Agreement or as may subsequently be agreed
to in writing by the Warrant Agent and the Company, subject to the Section 8.11(c);

 

(b)
shall have no obligation to effect any delivery of Warrant ADSs other than to instruct the Depositary with respect to that delivery;

 

(c)
shall be regarded as making no representations and having no responsibilities as to the validity, sufficiency, value, or genuineness
of the Warrants or any Warrant Shares or Warrant ADSs;

 

(d)
shall not be obligated to take any legal action under this Warrant Agreement; if, however, the Warrant Agent determines, in its sole
and absolute discretion, to take any legal action under this Warrant Agreement, and where the taking of such action might, in its judgment,
subject or expose it to any expense or liability it shall not be required to act unless it has been furnished with an indemnity satisfactory
to it;

 

(e)
may rely on and shall be fully authorized and protected in acting or failing to act upon any certificate, instrument, opinion, notice,
letter, telegram, telex, facsimile transmission or other document or security delivered to the Warrant Agent and believed by it to be
genuine and to have been signed by the proper party or parties;

 

(f)
shall not be liable or responsible for any recital or statement contained in the Registration Statement or any other documents relating
thereto, this Warrant Agreement or any Warrant Certificate except as to its countersignature thereof, or be required to verify the same,
but all such statements and recitals are and shall be deemed to have been made by the Company only;

 

(g)
shall not have any liability for or be under any responsibility in respect of the validity of this Warrant Agreement or the execution
and delivery hereof (except the due execution hereof by the Warrant Agent ) or in respect of the legality or validity or execution of
any Warrant Certificate (including in the case of book entry shares, by notation in book entry accounts reflecting ownership), except
its countersignature thereof; nor shall it be responsible for any breach by the Company of any covenant or failure by the Company to
satisfy any condition contained in this Warrant Agreement or in any Warrant Certificate; nor shall it be liable or responsible for modification
by or order of any court, tribunal, or governmental authority in connection with the foregoing, any change in the exercisability of the
Warrant ADSs or any adjustment required under this Warrant Agreement or responsible for the manner, method or amount of any such adjustment
or the ascertaining of the existence of facts that would require any such adjustment;

 

    	11

     

    

 

(h)
shall not be liable or responsible for any failure on the part of the Company to comply with any of its covenants and obligations relating
to the Warrants, including without limitation obligations under this Warrant Agreement and applicable securities laws;

 

(i)
may rely on and shall be fully authorized and protected in acting or failing to act upon the written, telephonic or oral instructions
with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement (or supplementing or qualifying
any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions with respect to the performance
of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for advice or instructions in connection
with the Warrant Agent’s duties hereunder, and the Warrant Agent shall not be liable for any delay in acting while waiting for
those instructions; any applications by the Warrant Agent for written instructions from the Company may, at the option of the Warrant
Agent , set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this Warrant Agreement and the date
on or after which such action shall be taken or such omission shall be effective; the Warrant Agent shall not be liable for any action
taken by, or omission of, the Warrant Agent in accordance with a proposal included in such application on or after the date specified
in such application (which date shall not be less than five Business Days after the date such application is sent to the Company, unless
the Company shall have consented in writing to any earlier date) unless prior to taking any such action, the Warrant Agent shall have
received written instructions in response to such application specifying the action to be taken or omitted;

 

(j)
may consult with counsel satisfactory to the Warrant Agent and the advice or opinion of such counsel shall be full and complete authorization
and protection in respect of any action taken, suffered, or omitted by it hereunder in accordance with the advice or opinion of such
counsel;

 

(k)
may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through
its attorneys or agents, and the Warrant Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct
of any such attorneys or agents or for any loss to the Company, to Holders or any other person resulting from any such act, omission,
default, neglect or misconduct, absent gross negligence or willful misconduct in the selection and continued employment thereof (which
gross negligence or willful misconduct must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

 

(l)
is not authorized, and shall have no obligation, to pay any brokers, dealers, or soliciting fees to any person;

 

(m)
shall not be required hereunder to comply with the laws or regulations of any country other than the United States of America or any
political subdivision thereof; and Warrant Agent may, after consulting with the Company to the extent practical, consult with foreign
counsel, the fees and expenses of which shall be at the Company’s expense, to resolve any foreign law issues that may arise as
a result of the Company or any other party being subject to the laws or regulations of any foreign jurisdiction;

 

(n)
any stockholder, affiliate, member, director, officer, agent, representative or employee of the Warrant Agent may buy, sell or deal in
any of the Warrant ADSs or other securities of the Company or may become pecuniarily interested in any transaction in which the Company
may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not the Warrant
Agent under this Warrant Agreement. Nothing herein shall preclude the Warrant Agent or any such stockholder, affiliate, director, member,
officer, agent, representative or employee from acting in any other capacity for the Company or for any other person; and

 

(o)
shall not be required to take notice or be deemed to have notice of any event or condition hereunder, including any event or condition
that may require action by the Warrant Agent , unless the Warrant Agent shall be specifically notified in writing of such event or condition
by the Company, and all notices or other instruments required by this Warrant Agreement to be delivered to the Warrant Agent must, in
order to be effective, be received by the Warrant Agent as specified in Section 8.10 hereof, and in the absence of such notice so delivered,
the Warrant Agent may conclusively assume no such event or condition exists.

 

    	12

     

    

 

8.3
(a) In the absence of gross negligence or willful misconduct on its part (which gross negligence or willful misconduct must be determined
by a final, non-appealable judgment of a court of competent jurisdiction), the Warrant Agent shall not be liable for any action taken,
suffered, or omitted by it or for any error of judgment made by it in the performance of its duties under this Warrant Agreement. Anything
in this Warrant Agreement to the contrary notwithstanding, in no event shall Warrant Agent be liable for special, indirect, incidental,
consequential or punitive losses or damages of any kind whatsoever (including but not limited to lost profits), even if the Warrant Agent
has been advised of the possibility of such losses or damages and regardless of the form of action. Any liability of the Warrant Agent
will be limited in the aggregate to the amount of fees (but not reimbursed costs, charges or expenses) paid by the Company hereunder
for the twelve months preceding the event for which recovery from the Warrant Agent is being sought. The Warrant Agent shall not be liable
for any failures, delays or losses, arising directly or indirectly out of conditions beyond its reasonable control including, but not
limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages or labor disputes, fires, civil disobedience,
riots, rebellions, storms, electrical or mechanical failure, computer hardware or software failure, communications facilities failures
including telephone failure, war, terrorism, insurrection, earthquakes, floods, epidemics, pandemics, acts of God or similar occurrences.

 

(b)
In the event any question or dispute arises with respect to the proper interpretation of the Warrants or the Warrant Agent’s duties
under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall not be required to act and shall
not be held liable or responsible for its refusal to act until the question or dispute has been judicially settled (and, if appropriate,
it may, but shall not be required to, file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered
by a court of competent jurisdiction, binding on all persons interested in the matter which is no longer subject to review or appeal,
or settled by a written document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder.
In addition, the Warrant Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement
by all the Holders and all other persons that may have an interest in the settlement.

 

(c)
The Warrant Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect
to any action or default by the Company, including, without limiting the generality of the foregoing, any duty or responsibility to initiate
or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Company on behalf of any Holder.

 

8.4
The Company covenants to indemnify the Warrant Agent and hold it harmless from and against loss, liability, damage, judgment, fine, penalty,
claim, demand, settlement, cost or expense (including, without limitation, the reasonable fees and expenses of legal counsel) that may
be paid to any third party, incurred or suffered by it, or which it may become subject, without gross negligence or illegal or willful
misconduct on the part of the Warrant Agent (which gross negligence or willful misconduct must be determined by a final, non-appealable
judgment of a court of competent jurisdiction), for any action taken, suffered, or omitted to be taken by the Warrant Agent in connection
with the execution, acceptance, administration, exercise and performance of its duties under this Warrant Agreement, including the costs
and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or enforcing its rights hereunder
against any third party. The provisions under Sections 8.1, 8.2, 8.3 and this Section 8.4 shall survive the expiration of the Warrant
ADSs and the termination of this Warrant Agreement and the resignation, replacement or removal of the Warrant Agent. The costs and expenses
incurred in enforcing this right of indemnification shall be borne by the Company.

 

8.5
Unless terminated earlier by the parties hereto, this Warrant Agreement shall terminate 90 days after the earlier of the Expiration Date
and the date on which no Warrants remain outstanding (the “Termination Date”). On the Business Day following the Termination
Date, the Agent shall deliver to the Company any entitlements, if any, held by the Warrant Agent under this Warrant Agreement. The Agent’s
right to be indemnified and held harmless and to be reimbursed for fees, charges and out-of-pocket expenses as provided in this Section
8 shall survive the termination of this Warrant Agreement.

 

8.6
If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court, this Warrant Agreement shall
be construed and enforced as if such provision had not been contained herein and shall be deemed an agreement among the parties to it
to the full extent permitted by applicable law; provided, however, that if such excluded provision shall adversely affect the rights,
immunities, liabilities, duties or obligations of the Warrant Agent, the Warrant Agent shall be entitled to resign immediately upon written
notice to the Company.

 

    	13

     

    

 

8.7
The Company represents and warrants that (a) it is duly incorporated and validly existing under the laws of its jurisdiction of incorporation,
(b) the offer and sale of the Warrants and the execution, delivery and performance of all transactions contemplated thereby (including
this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result in a breach of or constitute
a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement or instrument
to which it is a party or is bound, (c) this Warrant Agreement has been duly executed and delivered by the Company and constitutes the
legal, valid, binding and enforceable obligation of the Company, (d) the Warrants will comply in all material respects with all applicable
requirements of law and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof in connection
with the offering of the Warrants.

 

8.8
In the event of inconsistency between this Warrant Agreement and the descriptions in the Registration Statement and the ADS Registration
Statement, as they may from time to time be amended, the terms of this Warrant Agreement shall control.

 

8.9
Set forth in Annex C hereto is a list of the names and specimen signatures of the persons authorized to act for the Company under
this Warrant Agreement. The Company shall, from time to time, certify to the Warrant Agent the names and signatures of any other persons
authorized to act for the Company under this Warrant Agreement (collectively, the “Authorized Representatives”). The
Warrant Agent shall be fully authorized and protected in relying upon the advice or instructions received from any such Authorized Representatives.

 

8.10
Except as expressly set forth elsewhere in this Warrant Agreement, all notices, instructions and communications under this Warrant Agreement
shall be in writing, by overnight delivery service, first-class mail, postage prepaid, properly addressed shall be effective upon receipt
and shall be addressed, if to the Company, to its address set forth beneath its signature to this Warrant Agreement, or, if to the Warrant
Agent, to:

 

Computershare
Inc.

Computershare
Trust Company, N.A.

150
Royall Street

Canton,
MA 02021

Attention:
Client Services

 

or
to such other address of which a party hereto has notified the other party; and, if to a Holder made if sent by first-class mail, postage
prepaid, or overnight delivery service, addressed to such Holder at the last address of such Holder set forth for such holder in the
Warrant Register.

 

8.11
(a) This Warrant Agreement shall be governed by and construed in accordance with the law of the State of New York. All actions and
proceedings relating to or arising from, directly or indirectly, this Warrant Agreement may be brought in courts of the State of New
York or of the United States of America sitting within the Borough of Manhattan in the City and State of New York. The Company hereby
submits to the personal jurisdiction of such courts and consents that any service of process may be made by certified or registered mail,
return receipt requested, directed to the Company at its address last specified for notices hereunder. Each of the parties hereto hereby
waives the right to a trial by jury in any action or proceeding arising out of or relating to this Warrant Agreement.

 

(b)
This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto. This Warrant
Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without the prior written consent of the
other party, which the other party will not unreasonably withhold, condition or delay; except that (i) consent is not required for an
assignment or delegation of duties by Warrant Agent to any affiliate of Warrant Agent and (ii) any reorganization, merger, consolidation,
sale of assets or other form of business combination by Warrant Agent or the Company shall not be deemed to constitute an assignment
of this Warrant Agreement.

 

    	14

     

    

 

(c)
No provision of this Warrant Agreement may be amended, modified or waived, except in a written document signed by both parties. The Company
and the Warrant Agent may amend or supplement this Warrant Agreement without the consent of any Holder for the purpose of curing any
ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions
with respect to matters or questions arising under this Warrant Agreement as the parties may deem necessary or desirable and that the
parties determine, in good faith, shall not adversely affect the interest of the Holders in any material respect. All other amendments
and supplements shall require the vote or written consent of Holders of a majority of the then outstanding Warrants, provided,
however, that no modification of the terms (including but not limited to the adjustments described in Section 4 herein) upon which
the Warrants are exercisable or the rights of the holders of Warrants to receive payments in cash from the Company, or no reduction of
the percentage required for consent to modification of this Warrant Agreement or no requirement for a holder of Warrants in book entry
or electronic form held through DTC to deliver any ink-original Election to Purchase or any medallion guarantee (or other type of guarantee
or notarization) of an Election to Purchase or reimbursement to the Holder pursuant to Section 6 may be made without the consent of the
Holder of each outstanding Warrant affected thereby. As a condition precedent to the Warrant Agent executing any amendment or supplement,
the Company shall deliver a certificate from an Authorized Representative which states that the proposed supplement or amendment is in
compliance with the terms of this Section 8.11(c). Notwithstanding anything in this Warrant Agreement to the contrary, the Warrant Agent
shall not be required to execute any supplement or amendment to this Warrant Agreement that it has determined would adversely affect
its own rights, duties, obligations or immunities under this Warrant Agreement.

 

8.12
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Warrant Shares or Warrant ADSs upon the exercise of Warrants, but the Company
may require the Holders to pay any transfer taxes in respect of the Warrants or such shares. The Warrant Agent may refrain from registering
any transfer of Warrants or any delivery of any Warrant ADSs unless or until the persons requesting the registration or issuance shall
have paid to the Warrant Agent for the account of the Company the amount of such tax or charge, if any, or shall have established to
the reasonable satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has been paid.

 

8.13
Resignation of Warrant Agent.

 

8.13.1
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving thirty (30) days’ notice in writing to the Company,
or such shorter period of time agreed to by the Company. The Company may terminate the services of the Warrant Agent, or any successor
Warrant Agent, after giving thirty (30) days’ notice in writing to the Warrant Agent or successor Warrant Agent. In the event any
transfer agency relationship in effect between the Company and the Warrant Agent terminates, the Warrant Agent will be deemed to have
resigned automatically and be discharged from its duties under this Warrant Agreement as of the effective date of such termination, If
the office of the Warrant Agent becomes vacant by resignation, termination or incapacity to act or otherwise, the Company shall appoint
in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period
of 30 days after it has been notified in writing of such resignation or incapacity by the Warrant Agent, then the Warrant Agent or any
Holder may apply to any court of competent jurisdiction for the appointment of a successor Warrant Agent at the Company’s cost.
Pending appointment of a successor to such Warrant Agent, either by the Company or by such a court, the duties of the Warrant Agent shall
be carried out by the Company. Any successor Warrant Agent (but not including the initial Warrant Agent), whether appointed by the Company
or by such court, shall be a person organized and existing under the laws of any state of the United States of America, in good standing,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed,
and except for executing and delivering documents as provided in the sentence that follows, the predecessor Warrant Agent shall have
no further duties, obligations, responsibilities or liabilities hereunder, but shall be entitled to all rights that survive the termination
of this Warrant Agreement and the resignation or removal of the Warrant Agent , including but not limited to its right to indemnity hereunder.
If for any reason it becomes necessary or appropriate or at the request of the Company, the predecessor Warrant Agent shall execute and
deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights
of such predecessor Warrant Agent hereunder, except the rights and immunities retained by the predecessor Warrant Agent under the terms
hereof; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver at the expense of the
Company any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all
such authority, powers, rights, immunities, duties, and obligations.

 

    	15

     

    

 

8.13.2
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the ADSs not later than the effective date of any such appointment.

 

8.13.3
Merger or Consolidation of Warrant Agent. Any person into which the Warrant Agent may be merged or converted or with which it
may be consolidated or any person resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party
or any person succeeding to the shareowner services business of the Warrant Agent or any successor Warrant Agent shall be the successor
Warrant Agent under this Warrant Agreement, without any further act or deed. For purposes of this Warrant Agreement, “person”
shall mean any individual, firm, corporation, partnership, limited liability company, joint venture, association, trust or other entity,
and shall include any successor (by merger or otherwise) thereof or thereto.

 

9.
Miscellaneous Provisions.

 

9.1
Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be implied
from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than
the parties hereto and the Holders any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof.

 

9.2
Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office
of the Warrant Agent designated for such purpose for inspection by any Holder. Prior to such inspection, the Warrant Agent may require
any such holder to provide reasonable evidence of its interest in the Warrants.

 

9.3
Counterparts. This Warrant Agreement may be executed in any number of original, facsimile or electronic counterparts and each
of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one
and the same instrument.

 

9.4
Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall
not affect the interpretation thereof.

 

9.5
Further Assurance. The Company agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed,
acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required or requested by
the Warrant Agent for the carrying out or performing by the Warrant Agent of the provisions of this Warrant Agreement.

 

IN
WITNESS WHEREOF, this Warrant Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	TC
    BIOPHARM (HOLDINGS) PLC
	 	 
	 	By:	 
	 	Name:
	 	Title:
	 	 
	 	Address
    for notices:
	 	Maxim
    1, 2 Parklands Way
	 	Holytown,
    Motherwell, ML1 4WR
	 	Scotland,
    United Kingdom
	 	Attention:
    Chief Financial Officer
	 	Telephone:
    +44 (0) 141 433 7557
	 	Facsimile:
	 	E-mail:
	 	 
	 	Computershare
    Inc.,
	 	Computershare
    Trust Company, N.A.,
	 	As
    Warrant Agent 
	 	 
	 	By:	            
	 	Name:
	 	Title:

 

Annex
A Form of Warrant Certificate

Exhibit
A – Notice of Exercise

Exhibit
B – Assignment Form

Annex
B – Warrant Certificate Request Notice

Annex
C – Global Warrant Request Notice

Annex
C Authorized Representatives

Annex
D Form of Warrant Certificate Request Notice

 

    	16

     

    

 

ANNEX
A

 

Warrant
Certificate

 

PURCHASE
WARRANT FOR ADSs (ORDINARY SHARE)

 

TC
BIOPHARM (HOLDINGS) PLC

 

	Number
    of ADSs: [_______]	Initial Exercise Date:

                                                                                [_______], 2022

 

This
certifies that the person whose name and address appears below, or registered assigns, is the registered owner of the number of Warrants
set forth herein. Each Warrant entitles its registered holder to purchase from TC BioPharm (Holdings) plc, a company incorporated in
Scotland at any time prior to 5:00 P.M. (New York City time) on _________, 2025, at the designated office of Computershare Inc. and Computershare
Trust Company, N.A., as warrant agent, one American Depositary Share, each ADS representing one (1) ordinary share, par value £0.01,
of the Company, upon payment of the exercise price set forth below in Section 4(a), subject to possible adjustments as provided herein.
The Company will pay the issuance fee for each ADS issued pursuant to the Warrants to the Depositary under the Deposit Agreement.

 

This
Warrant Certificate, with or without other Warrant Certificates, upon surrender at the designated office of the Warrant Agent, may be
exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or
Warrant Certificates surrendered. A transfer of the Warrants evidenced hereby may be registered upon surrender of this Warrant Certificate
at the designated office of the Warrant Agent by the registered holder in person or by a duly authorized attorney, properly endorsed
or accompanied by proper instruments of transfer, a signature guarantee, and such other and further documentation as the Warrant Agent
may reasonably request and duly stamped as may be required by the law of the State of New York and of the United States of America.

 

The
terms and conditions of the Warrants and the rights and obligations of the holder of this Warrant Certificate are set forth in the Warrant
Agency Agreement dated as of __________,.

 

Section
1. Definitions. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this
Section 1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“ADS”
means an American Depositary Share, and ADSs means American Depositary Shares.

 

“American
Depositary Shares” means the ADSs issuable under the Deposit Agreement representing ordinary shares of the Company.

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then
listed or quoted on a Trading Market, the Bid Price of the ADSs for the time in question (or the nearest preceding date) on the Trading
Market on which the ADSs is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the ADSs
for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the ADSs are not then listed or quoted for trading
on OTCQB or OTCQX and if prices for the ADSs are then reported on the Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent Bid Price per share of the ADSs so reported, or (d) in all other cases, the fair
market value of an ADS as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    	17

     

    

 

“Board
of Directors” means the board of directors of the Company.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Company”
means TC BioPharm (Holdings) plc.

 

“Deposit
Agreement” means the deposit agreement between the Company and Bank of New York Mellon, dated January __, 2022.

 

“Exercise
Price” means the price per ADS at which the ADSs may be purchased at the time a Warrant is exercised, which price is set forth
in Section 4(a).

 

“Expiration
Date” is as defined in Section 4(b).

 

“Ordinary
Shares” means the ordinary shares, par value £0.01 per share of the Company, which may be represented as American Depositary
Shares, or ADSs.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Registration
Statement” means the Company’s registration statement on Form F-1, as amended (File No.333- 260492), relating to the
Warrants and the ordinary shares, and the registration statement filed by the Bank of New York Mellon, on Form F-6 (File No. 333-262149
relating to the ADSs.

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Trading
Day” means any day on which the ADSs are traded on the Trading Market, or, if the Trading Market is not the principal trading
market for the ADSs, then on the principal securities exchange or securities market in the United States on which the ADSs are then traded.

 

“Trading
Market” means NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New
York Stock Exchange on the date in question (or any successors to any of the foregoing).

 

“Transfer
Agent” means Computershare Investor Services plc, the current transfer agent of the Company, with a mailing address of The
Pavilions Bridgwater Road, Bristol BS99 6ZZ United Kingdom and any successor transfer agent of the Company.

 

    	18

     

    

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed or quoted
on a Trading Market, the daily volume weighted average price of the ADSs for such date (or the nearest preceding date) on the Trading
Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) the volume weighted average price of the ADSs for such date (or the nearest preceding date)
on the OTC Bulletin Board, (c) if the ADSs are not then listed or quoted for trading on the OTC Bulletin Board and if prices for the
ADSs are then reported in the OTCQB maintained by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent Bid Price per ADS so reported, or (d) in all other cases, the fair market value of an ADS as determined
by an independent appraiser selected in good faith by the Company, the fees and expenses of which shall be paid by the Company.

 

“Warrant
Agency Agreement” means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company
and the Warrant Agent.

 

“Warrant
Agent” means Computershare Inc., a Delaware corporation, and its wholly owned subsidiary, Computershare Trust Company, N.A.,
a federally chartered trust company and any successor warrant agent of the Company.

 

“Warrants”
means this Warrant and other warrants of like tenor issued by the Company pursuant to the Registration Statement.

 

Section
2. Warrants.

 

a)
Form of Warrants. The Warrants shall be registered securities in book entry form and shall be evidenced by a global certificate
(“Global Certificate”) in the form of this Annex A to the Warrant Agreement, which shall be deposited on behalf
of the Company with a custodian for The Depository Trust Company (“DTC”) and registered in the name of Cede &
Co., as nominee of DTC. If DTC subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may
instruct the Warrant Agent regarding making other arrangements for book-entry settlement. In the event that the Warrants are not eligible
for, or it is no longer necessary to have the Warrants available in, book-entry form, the Company may instruct the Warrant Agent to provide
written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Certificate, and the Company shall instruct the
Warrant Agent to deliver each holder of the Warrants separate certificates in the form of Annex A evidencing Warrants (“Definitive
Certificates” and, together with the Global Certificate, “Warrant Certificates”) registered as requested
through the DTC system. In the event Definitive Certificates are delivered to the holders, the transfer, exchange or exercise of the
Warrants shall be conducted in accordance with the customary procedures of the Warrant Agent. The Company shall use its best efforts
to enable the Warrants be “DTC eligible” so that the interests in the Warrants may be held in book-entry through DTC for
the term of the Warrants.

 

b)
Exchange of Interest in Global Certificate for Definitive Certificate. Notwithstanding Section 2(a) above, a holder of a security
entitlement in Warrants evidenced by the Global Certificate has the right to elect at any time to exchange it for a Definitive Certificate
evidencing the same number of Warrants. Upon written notice by a participant having Warrants credited to its DTC account for the exchange
of some or all that entitlement for a Definitive Certificate evidencing the same number of Warrants, which request shall be in the form
attached to the Warrant Agreement in the form of Annex B (a “Warrant Certificate Request Notice” and the date
of delivery of such Warrant Certificate Request Notice by the Holder, the “Warrant Certificate Request Notice Date”
and the exchange made pursuant to the Warrant Certificate Request Notice, a “Warrant Exchange”), and upon surrender
by that Participant of the Warrants to be exchanged to the Warrant Agent through DTC’s system, the Warrant Agent shall, without
unreasonable delay, effect the Warrant Exchange by issuing and delivering a Definitive Certificate for such number of Warrants in the
name and mailed to the address set forth in the Warrant Certificate Request Notice. Such Definitive Certificate shall be dated the original
issue date of the Warrants, shall be manually executed by an authorized signatory of the Company and shall be in the form attached to
the Warrant Agreement as Annex A In connection with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant
Agent to deliver, the Definitive Certificate to the specified holder within ten (10) Business Days of the Warrant Certificate Request
Notice pursuant to the delivery instructions in the Warrant Certificate Request Notice (the “Warrant Certificate Delivery Date”).

 

    	19

     

    

 

Section
3. Issuance and Registration of Warrants.

 

a)
Warrant Register. Upon the receipt of all relevant information from the Company or its agents, the Warrant Agent shall maintain
books (“Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants.

 

b)
Issuance of Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue the Global Certificate and deliver
the Warrants in the DTC book-entry settlement system in accordance with written instructions delivered to the Warrant Agent by the Company.
Ownership of beneficial interests in the Warrants shall be shown on, and the transfer of such ownership shall be effected through, records
maintained (i) by DTC and (ii) by institutions that have accounts with DTC (each, with respect to a Warrant in its account, a “Participant”).

 

c)
Beneficial Owner; Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name that Warrant shall be registered on the Warrant Register (the “Holder”,
which shall include, if the Warrants are held in “street name,” a participant or a designee appointed by such participant)
as the absolute owner of such Warrant for purposes of any exercise thereof, and for all other purposes, and neither the Company nor the
Warrant Agent shall be affected by any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the Company,
the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or other authorization
furnished by DTC governing the exercise of the rights of a holder of a beneficial interest in any Warrant. The rights of beneficial owners
in a Warrant evidenced by the Global Certificate shall be exercised by the Holder through the DTC system.

 

d)
Execution. The Warrant Certificates shall be executed on behalf of the Company by any
authorized officer of the Company (an “Authorized Officer”), which need not be the same authorized signatory for all
of the Warrant Certificates, either manually or by facsimile signature. The Warrant Certificates shall be countersigned by an authorized
signatory of the Warrant Agent either by manual, electronic or facsimile signature, which need not be the same signatory for all of the
Warrant Certificates, and no Warrant Certificate shall be valid for any purpose unless so countersigned. In case any Authorized Officer
of the Company that signed any of the Warrant Certificates ceases to be an Authorized Officer of the Company before countersignature
by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be countersigned by the Warrant
Agent, issued and delivered with the same force and effect as though the person who signed such Warrant Certificates had not ceased to
be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by any person who, at the actual date
of the execution of such Warrant Certificate, shall be an Authorized Officer of the Company authorized to sign such Warrant Certificate,
although at the date of the execution of this Warrant any such person was not such an Authorized Officer. The rights of holders of Warrant
Certificates shall be identical regardless of the Authorized Officer signing for and on behalf of the Company and of the authorized signatory
of the Warrant Agent signing such certificates.

 

e)
Registration of Transfer. At any time at or prior to the Expiration Date (as defined
below), a transfer of any Warrants may be registered and any Warrant Certificate or Warrant Certificates may be split up, combined or
exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or
Warrant Certificates surrendered. Any Holder desiring to register the transfer of Warrants or to split up, combine or exchange any Warrant
Certificate shall make such request in writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate
or Warrant Certificates evidencing the Warrants the transfer of which is to be registered or that is or are to be split up, combined
or exchanged and, in the case of registration of transfer, shall provide a signature guarantee by an “eligible guarantor institution”
that is a member or participant in the Securities Transfer Agents Medallion Program or other comparable “signature guarantee program.”
Thereupon, the Warrant Agent shall countersign and deliver to the person entitled thereto a Warrant Certificate or Warrant Certificates,
as the case may be, as so requested. The Company and the Warrant Agent may require payment by the Holder requesting a registration of
transfer of Warrants or a split-up, combination or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise
of the Warrants and issuance of Warrant ADS to the Holder) of a sum sufficient to cover any tax or governmental charge that may be imposed
in connection with such registration of transfer, split-up, combination or exchange, together with reimbursement to the Company and the
Warrant Agent of all reasonable expenses incidental thereto. The Warrant Agent shall not have any duty or obligation to take any action
under any section of this Warrant that requires the payment of taxes and/or charges unless and until it is satisfied that all such payments
have been made.

 

    	20

     

    

 

f)
Loss, Theft and Mutilation of Warrant Certificates. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security acceptable to the Warrant Agent, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates.
The Warrant Agent may receive compensation from the surety companies or surety agents for administrative services provided to them. Notwithstanding
anything herein to the contrary, in connection with a Warrant in book-entry form through DTC, no posting of a bond shall be required
under this Section 3(f).

 

g)
Proxies. The Holder of a Warrant may grant proxies or otherwise authorize any person, including participants and beneficial holders
that may own interests through participants, to take any action that a Holder is entitled to take under this Warrant; provided,
however, that at all times that Warrants are evidenced by a Global Certificate, exercise of those Warrants shall be effected on
their behalf by participants through DTC in accordance with the procedures administered by DTC.

 

Section
4. Exercise.

 

a)
Exercise Price. Each Warrant shall entitle the Holder, subject to the provisions of the of this Warrant, to purchase from the
Company the number of ADSs stated therein, at the price of $______[NTD: 125% of IPO share price] per ADS, subject to the
subsequent adjustments provided in Section 5 hereof.

 

b)
Duration of Warrants. Warrants may be exercised only during the period (“Exercise Period”) commencing on the
Issuance Date and terminating at 5:00 P.M., New York City time (the “close of business”) on _________, 2025 [NTD:
Three years after IPO effective date] (“Expiration Date”). Each Warrant not exercised on or before the Expiration
Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement shall cease at the close
of business on the Expiration Date.

 

c)
Exercise. Subject to the provisions of this Warrant, a Holder (or a participant acting on behalf of a Holder in accordance with
DTC procedures) may exercise Warrants by delivering to the Warrant Agent, not later than 5:00 P.M., New York City time, on any Business
Day during the Exercise Period an election to purchase the Warrant ADSs to be exercised (A) in the form included in Exhibit A
to this Warrant or (B) via an electronic warrant exercise through the DTC system (each, an “Election to Purchase”).
Within one Trading Day following the delivery of the Election to Purchase, the Holder shall deliver (i) the Warrants to be exercised
by (A) surrender of the Warrant Certificate evidencing the Warrants to the Warrant Agent at its office designated for such purpose or
(B) delivery of the Warrants to an account of the Warrant Agent at DTC designated for such purpose in writing by the Warrant Agent to
DTC from time to time, and (ii) the Exercise Price for each Warrant to be exercised (and, if applicable, any taxes or charges due in
connection with the exercise of such Warrants), in lawful money of the United States of America by (A) certified or official bank check
or wire transfer from a United States bank payable to the Warrant Agent or (B) payment to the Warrant Agent through the DTC system.

 

    	21

     

    

 

If
any of (i) the Warrants, (ii) the Election to Purchase, or (iii) the Exercise Price therefor (and, if applicable, any taxes or charges
due in connection with the exercise of such Warrants), is received by the Warrant Agent on any date after 5:00 P.M., New York City time,
or on a date that is not a Trading Day, the Warrants with respect thereto will be deemed to have been received and exercised on the Trading
Day next succeeding such date. The “Exercise Date” will be the date on which the Election to Purchase is delivered
to the Warrant Agent; however, the Warrants shall not be deemed to be exercised if the Warrants and the Exercise Price therefor are not
received by the Warrant Agent on or prior to the Trading Day following the delivery of the Election to Purchase. If the Warrants are
received or deemed to be received after the Expiration Date, the exercise thereof will be null and void and any funds delivered to the
Warrant Agent will be returned to the Holder or participant, as the case may be, as soon as practicable.

 

The
Warrant Agent shall deposit all funds received by it in payment of the Exercise Price in the account maintained by the Warrant Agent
in its name as agent for the Company. The Warrant Agent shall remit to the Company funds received for warrant exercises in a given month
by the fifth Business Day of the following month by wire transfer to an account designated by the Company, or as otherwise from time
to time as reasonably requested by the Company. All funds received by Computershare under this Agreement that are to be distributed or
applied by Computershare in the performance of services hereunder (the “Funds”) shall be held by Computershare as agent for
the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company. Until
paid pursuant to the terms of this Warrant Agreement, Computershare will hold the Funds in deposit accounts with U.S. commercial banks
with Tier 1 capital exceeding $1 billion or with ratings above investment grade by S&P Global Ratings (LT Local Issuer Credit Rating),
Moody’s Investors Service (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg
L.P.). Computershare shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made
by Computershare in accordance with this Section 4(c), including any losses resulting from a default by any bank, financial institution
or other third party. Computershare may from time to time receive interest, dividends or other earnings in connection with such deposits.
Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party.

 

If
less than all the Warrants evidenced by a surrendered Warrant Certificate are exercised, the Warrant Agent shall split up the surrendered
Warrant Certificate and return to the Holder a Warrant Certificate evidencing the Warrants that were not exercised.

 

d)
Issuance of Warrant Securities. The Warrant Agent shall, by 11:00 a.m., New York City time, on the Trading Day following the Exercise
Date of any Warrant, advise the Company, the transfer agent and registrar for ordinary shares and the Depositary, in respect of (i) the
number of Warrant ADSs indicated on the Election to Purchase as issuable upon such exercise with respect to such exercised Warrants,
(ii) the instructions of the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of
the Warrant ADSs and the number of Warrants that remain outstanding after such exercise and (iii) such other information as the Company
or the Depositary shall reasonably request.

 

The
Company shall, by no later than 5:00 P.M., New York City time, on the fourth Trading Day following the Exercise Date of any Warrant,
provided the funds in payment of the Exercise Price for each Warrant to be exercised have cleared on the Trading Day following the Exercise
Date, cause its registrar to deliver the Warrant ADSs issuable upon that exercise to the Depositary’s custodian for deposit under
the Deposit Agreement and instruct the Depositary to deliver the Warrant ADSs issuable upon that deposit of ordinary shares as requested
in the Election to Purchase Warrant ADSs.

 

    	22

     

    

 

The
Company shall, by no later than 5:00 P.M., New York City time, on the fifth Trading Day following the Exercise Date of any Warrant, provided
the funds in payment of the Exercise Price for each Warrant to be exercised have cleared on the Trading Day following the Exercise Date,
cause the Depositary to deliver the Warrant ADSs to the Holder pursuant to the Election to Purchase (the “Warrant ADS Delivery
Date”).

 

e)
Valid Issuance. All Warrant ADSs issuable by the Company upon the proper exercise of a Warrant in conformity with this Warrant
Agreement shall be validly issued and fully paid.

 

f)
No Fractional Exercise. No fractional Warrant ADSs will be issued upon the exercise of the Warrant, but rather the Company shall
adjust the number of Warrant ADSs issued up or down to the nearest integral multiple of the number of ADSs representing the ordinary
shares.

 

g)
No Transfer Taxes. The Company shall not be required to pay any stamp or other tax or charge required to be paid in connection
with the exercise of Warrants; and the Company shall not be required to issue or deliver any ADSs until such tax or other charge shall
have been paid or it has been established to the satisfaction of the Company and the Warrant Agent that no such tax or other charge is
due. For purposes of clarity, the Company shall pay any stamp or other tax or charge required to be paid in connection with any issuance
to the Holder of the Warrant ADSs upon the exercise of Warrants.

 

h)
Date of Issuance. (a) The Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
ADSs only on the Warrant ADS Delivery Date, except that, if the Exercise Date is a date when the stock transfer books of the Company
are closed, such person shall be deemed to have become the holder of such shares at the open of business on the next succeeding date
on which the stock transfer books are open; provided, however, Warrant ADSs will not be registered or issued until the Depositary receives
notice from its custodian that the ordinary shares relating to the ADSs have been deposited under the Deposit Agreement; provided further,
however, that the Company shall take all reasonable steps to ensure the Warrant ADSs are delivered to the Holder on or prior to the Warrant
ADS Delivery Date in accordance with Section 4(d) hereof and, if the Warrant ADSs are not delivered to the Holder on or prior to the
Warrant ADS Delivery Date, the provisions of Section 4(k) shall apply.

 

No
exercising Holder, which Holder effected a Warrant Exchange pursuant to Section 2(b) prior to the Exercise Date, shall be required to
surrender its Warrant to the Warrant Agent, unless such exercise is for the remaining numbers of ADSs issuable upon exercise of such
Warrant, in which case the Holder shall deliver the Warrant Certificate to the Warrant Agent within three (3) Business Days.

 

i)
Restrictive Legend Events. The Company shall use its commercially reasonable efforts to maintain the effectiveness of the Registration
Statement and the ADS Registration Statement and the current status of the prospectuses included therein or to file and maintain the
effectiveness of another registration statement and another current prospectus covering the Warrants and the Warrant ADSs (and related
ordinary shares) at any time that the Warrants are exercisable. The Company shall provide to the Warrant Agent and each Holder prompt
written notice of any time that the Company is unable to deliver the Warrant ADSs via DTC transfer or otherwise without restrictive legend
because (A) the Commission has issued a stop order with respect to the Registration Statement or the ADS Registration Statement, (B)
the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement or the ADS Registration Statement,
either temporarily or permanently, (C) the Company has suspended or withdrawn the effectiveness of the Registration Statement or the
ADS Registration Statement, either temporarily or permanently, (D) the prospectuses contained in the Registration Statement and the ADS
Registration Statement are not available for the issuance of the Warrant ADSs to the Holder, (E) the Registration Statement or the ADS
Registration Statement or the prospectuses contained therein are not current and do not conform to the requirements of the applicable
rules and regulations, or the SEC has not declared effective a post-effective amendment to the Registration Statement or the ADS Registration
Statement are if one is required to be filed to update the disclosures therein, or (F) otherwise (each a “Restrictive Legend
Event”). To the extent that the Warrants cannot be exercised as a result of a Restrictive Legend Event or a Restrictive Legend
Event occurs after a Holder has exercised Warrants in accordance with the terms of the Warrants but prior to the delivery of the Warrant
ADSs, the Company shall, at the election of the Holder, which shall be given within five (5) days of receipt of such notice of the Restrictive
Legend Event, either rescind the previously submitted Election to Purchase and the Company shall return all consideration paid by registered
holder for such shares upon such.

 

    	23

     

    

 

j)
Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of
Warrant ADSs issuable in connection with any exercise, the Company shall promptly deliver to the Holder the number of Warrant ADSs that
are not disputed.

 

k)
Compensation for Buy-In on Failure to Timely Deliver Warrant ADSs Upon Exercise. In addition to any other rights available to
the Holder, if the Company fails to cause the Depositary to deliver the Warrant ADSs to the Holder pursuant to Section 4(d), and if after
such date the beneficial owner is required by its broker to purchase (in an open market transaction or otherwise) or the beneficial owner’s
brokerage firm otherwise purchases, ADSs or ordinary shares to deliver in satisfaction of a sale by the beneficial owner of the Warrant
ADSs, which the beneficial owner anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A)
pay in cash to the Holder the amount, if any, by which (x) the beneficial owner’s total purchase price (including brokerage commissions,
if any) for the Warrant ADSs so purchased exceeds (y) the amount obtained by multiplying (i) the number of Warrant ADSs, as applicable,
that the Company was required to deliver to the Holder in connection with the exercise at issue times (ii) the price at which the sell
order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the
Warrant and equivalent number of Warrant ADSs, as applicable, for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of Warrant ADSs, as applicable, that would have been issued had the Company
timely complied with its delivery obligations. For example, if the beneficial owner purchases ADSs having a total purchase price (including
brokerage commissions) of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrant ADSs with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required
to pay the Holder $1,000 for the benefit of the beneficial owner. The Holder shall provide the Company written notice indicating the
amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit right of a Holder to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver Warrant ADSs
upon exercise of Warrants as required pursuant to the terms of this Warrant Agreement. The Warrant Agent shall have no liability for
the Company’s failure to deliver to the Holders the Warrant ADSs as set forth in this Section 4(k).

 

In
addition, if the Company fails for any reason to deliver to the Holder the Warrant ADSs subject to an Election to Purchase by the Warrant
ADS Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
ADSs subject to such exercise (based on the VWAP of the ADSs on the date of the applicable Election to Purchase), $10 per Trading Day
for each Trading Day after such Warrant ADS Delivery Date until such Warrant ADSs are delivered or Holder rescinds such exercise. The
Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and
exercisable. In addition, if the Company fails to cause the Depository to transmit to the Holder the Warrant ADSs by the Warrant ADS
Delivery Date, then the Holder will have the right to rescind such exercise.

 

l)
Expenses. The Company shall pay all Warrant Agent and Depositary fees required for timely processing of any Election to Purchase
and all fees to DTC (or another established clearing corporation performing similar functions) required for electronic issuance and delivery
of the Warrant ADSs for timely delivery of Warrant ADSs on or prior to the Warrant ADSs Delivery Date. The Company shall pay all applicable
fees and expenses of the Depositary in connection with the issuance of the Warrants ADSs hereunder.

 

    	24

     

    

 

Section
5. Certain Adjustments.

 

a)
Adjustment upon Subdivisions or Combinations. If the Company at any time after the Issuance Date subdivides (by any stock split,
stock dividend, recapitalization, reorganization, scheme of arrangement or otherwise) its outstanding ordinary shares into a greater
number of ordinary shares or the ratio of ordinary shares per ADS is reduced (e.g., the ratio is changed from one ordinary share per
one ADS to two ordinary shares per one ADS), the Exercise Price in effect immediately prior to such subdivision will be proportionately
reduced and the number of Warrant ADSs will be proportionately increased. If the Company at any time after the Issuance Date combines
(by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) its outstanding ordinary shares
into a smaller number of ordinary shares or the ratio of ordinary shares per ADS is increased (e.g., the ratio is changed from one ordinary
shares per one ADS to three ordinary shares per one ADS), the Exercise Price in effect immediately prior to such combination will be
proportionately increased and the number of Warrant ADSs will be proportionately decreased. Any adjustment under this Section 5(a) shall
become effective at the close of business on the date the subdivision or combination or ratio change becomes effective. The Company shall
promptly notify the Warrant Agent in writing of any adjustment to the Warrants and give specific instructions to the Warrant Agent with
respect to any adjustments to the warrant register.

 

b)
Adjustment for Other Distributions. In the event the Company shall fix a record date for the making of a dividend or distribution
to all holders of ordinary shares of any evidences of indebtedness or assets or subscription rights, options or warrants (excluding those
referred to in Section 5(a) or other dividends paid out of retained earnings), then in each such case the Holder will, upon the exercise
of Warrants, be entitled to receive, in addition to the number of Warrant ADSs issuable thereupon, and without payment of any additional
consideration therefor, the amount of such dividend or distribution, as applicable, which such Holder would have held on the date of
such exercise had such Holder been the holder of record of such Warrant ADSs as of the date on which holders of ADSs became entitled
to receive such dividend or distribution. Such adjustment shall be made whenever any such distribution is made and shall become effective
immediately after the record date mentioned above.

 

c)
Reclassification, Consolidation, Purchase, Combination, Sale or Conveyance. If, at any time while the Warrants are outstanding,

 

	 	(i)	the
    Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
    another person;
	 	(ii)	the
    Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
    substantially all of its assets in one or a series of related transactions;
	 	(iii)	any
    direct or indirect purchase offer, tender offer or exchange offer (whether by the Company or another person) is completed pursuant
    to which holders of ordinary shares (including those represented by ADSs) are permitted to sell, tender or exchange their shares
    for other securities, cash or property and has been accepted by the holders of 50% or more of the total voting power of the Company’s
    ordinary shares (including those represented by ADSs) (not including any ordinary shares (including those represented by ADSs) held
    by the other person or other persons making or party to, or associated or affiliated with the other persons making, such purchase
    offer, tender offer or exchange offer); 
	 	(iv)	the
    Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
    of ADSs or ordinary shares or any compulsory share exchange pursuant to which the ADSs or ordinary shares are effectively converted
    into or exchanged for other securities, cash or property, or 
	 	(v)	the
    Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
    combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person
    whereby such other person acquires more than 50% of the total voting power of the Company’s ordinary shares (including those
    represented by ADSs) (not including any ordinary shares (including those represented by ADSs) held by the other person or other persons
    making or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement
    or other business combination) (each a “Fundamental Transaction”), 

 

    	25

     

    

 

then,
upon any subsequent exercise of a Warrant, the Holder shall have the right to receive, for each Warrant ADS that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, the number of shares, if any, of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, or depositary shares representing those shares, and any
additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by
a holder of the number of ADSs for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one ADS in such Fundamental Transaction and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of ADSs are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
following such Fundamental Transaction.

 

The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor
Entity”), to assume in writing all of the obligations of the Company under this Warrant Agreement in accordance with the provisions
of this Section 5(c) pursuant to written agreements in form reasonably satisfactory to the Warrant Agent and shall, upon the written
request of the Holder of Warrants, deliver to that Holder in exchange for those Warrants a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to those Warrants that is exercisable for a corresponding number
of shares of capital stock of such Successor Entity (or its parent entity), if any, plus any Alternate Consideration, receivable as a
result of such Fundamental Transaction by a holder of the number of ADSs for which those Warrants were exercisable immediately prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock,
if any, plus any Alternate Consideration (but taking into account the relative value of the ADSs or ordinary shares prior to such Fundamental
Transaction and the value of such shares of capital stock plus Alternate Consideration after that Fundamental Transaction, for the purpose
of protecting the economic value those Warrants had immediately prior to the consummation of such Fundamental Transaction). Upon the
occurrence of any such Fundamental Transaction the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Warrant Agreement and the Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant Agreement and the Warrant with the same effect as if such Successor Entity had been named as the Company
herein.

 

The
Company shall instruct the Warrant Agent in writing to mail, by first class mail, postage prepaid, to each Holder, written notice of
the execution of any such amendment, supplement or agreement with the Successor Entity. Any supplemented or amended agreement entered
into by the successor corporation or transferee shall provide for adjustments, which shall be as nearly equivalent as may be practicable
to the adjustments provided for in this Section 5(c). The Warrant Agent shall have no duty, responsibility or obligation to determine
the correctness of any provisions contained in such agreement or such notice, including but not limited to any provisions relating either
to the kind or amount of securities or other property receivable upon exercise of warrants or with respect to the method employed and
provided therein for any adjustments, and shall be entitled to rely conclusively for all purposes upon the provisions contained in any
such agreement. The provisions of this Section 5(c) shall similarly apply to successive reclassifications, changes, consolidations, mergers,
sales and conveyances of the kind described above.

 

    	26

     

    

 

d)
Other Events. If any event occurs of the type contemplated by the provisions of Section 5(a) or 5(b) but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights
with equity features to all holders of ADSs for no consideration), then the Company’s board of directors will, at its discretion
and in good faith, make an adjustment in the Exercise Price and the number of Warrant ADSs or designate such additional consideration
to be deemed issuable upon exercise of a Warrant, so as to protect the rights of the registered Holder. No adjustment to the Exercise
Price will be made pursuant to more than one sub-section of this Section 5 in connection with a single issuance.

 

e)
Notices of Changes in Warrant. Upon every adjustment of the Exercise Price or the number of Warrant ADSs issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise Price resulting
from such adjustment and the increase or decrease, if any, in the number of Warrant ADSs purchasable at such price upon the exercise
of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the
occurrence of any event specified in Sections 5(a) or 5(b), then, in any such event, the Company shall give written notice to each Holder,
at the last address set forth for such holder in the Warrant Register, as of the record date or the effective date of the event. Failure
to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant Agent shall be entitled
to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions provided by the Company
with respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Warrant, or any related matter,
and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with any such certificate,
notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be deemed to have knowledge of any such adjustment
unless and until it shall have received written notice thereof from the Company.

 

Section
6. Miscellaneous.

 

a)
No Rights as Stockholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Warrant be construed to confer upon a Holder, solely in its capacity as the registered holder of Warrants,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice of
meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance
to the Holder of the Warrant ADSs which it is then entitled to receive upon the due exercise of Warrants.

 

b)
Due Authorization. The Company represents and warrants that (a) it is duly incorporated and validly existing under the laws of
its jurisdiction of incorporation, (b) the offer and sale of the Warrants and the execution, delivery and performance of all transactions
contemplated thereby (including this Warrant) have been duly authorized by all necessary corporate action and will not result in a breach
of or constitute a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement
or instrument to which it is a party or is bound, (c) this Warrant has been duly executed and delivered by the Company and constitutes
the legal, valid, binding and enforceable obligation of the Company, (d) the Warrants will comply in all material respects with all applicable
requirements of law and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof in connection
with the offering of the Warrants.

 

c)
Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued
ordinary shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant Agreement.

 

    	27

     

    

 

d)
Authorized Shares. The Company covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant ADSs upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant ADSs may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the ordinary shares may be listed. The Company
covenants that all Warrant ADS which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant ADS in accordance herewith, be duly authorized, validly
issued and fully paid and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).

 

e)
No Rights as Stockholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered holder of
Warrants, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice
of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance
to the Holder of the Warrant ADSs which it is then entitled to receive upon the due exercise of Warrants.

 

f)
Restrictive Legends; Fractional Warrants. In the event that a Warrant Certificate surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not register that transfer until the Warrant Agent has received an opinion of counsel for the Company
stating that such transfer may be made and indicating whether the Warrants must also bear a restrictive legend upon that transfer. The
Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the transfer of or delivery
of a Warrant Certificate for a fraction of a Warrant. The Holder acknowledges that the Warrant ADSs acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws.

 

g)
Expense Reimbursement. The Company shall reimburse the Holder, upon the Holder’s request, for any reasonable fees charged
to the Holder by the Depositary in connection with the issuance or holding or sale of ADSs, Warrant ADSs and/or ordinary shares.

 

h)
Notices to Warrant Agent. Except as expressly set forth elsewhere in this Warrant Agreement, all notices, instructions and communications
under this Warrant Agreement shall be in writing, by overnight delivery service, first-class mail, postage prepaid, properly addressed
shall be effective upon receipt and shall be addressed, if to the Company, to its address set forth beneath its signature to this Warrant
Agreement, or, if to the Warrant Agent, to:

 

Computershare
Inc.

Computershare
Trust Company, N.A.

150
Royall Street

Canton,
MA 02021

Attention:
Client Services

 

or
to such other address of which a party hereto has notified the other party; and, if to a Holder made if sent by first-class mail, postage
prepaid, or overnight delivery service, addressed to such Holder at the last address of such Holder set forth for such holder in the
Warrant Register.

 

    	28

     

    

 

i)
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York,
Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant,
the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

j)
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Warrant ADSs upon the exercise of Warrants, but the Company may require the
Holders to pay any transfer taxes in respect of the Warrants or such shares. The Warrant Agent may refrain from registering any transfer
of Warrants or any delivery of any Warrant ADSs unless or until the persons requesting the registration or issuance shall have paid to
the Warrant Agent for the account of the Company the amount of such tax or charge, if any, or shall have established to the reasonable
satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has been paid.

 

k)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant ADSs, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any Warrant ADSs or as a shareholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

l)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

m)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant ADSs.

 

n)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Warrant Agent, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.

 

o)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

p)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

q)
Warrant Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued
subject to the Warrant Agency Agreement. Without limiting any of the rights and immunities of the Warrant Agent or modifying the Warrant
Agent’s express duties and obligations under the Warrant Agreement, to the extent any provision of this Warrant conflicts with
the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.

 

********************

 

(Signature
Page Follows)

 

    	29

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	TC
    BioPharm (Holdings) plc  	 
	 	       	 
	By:	 	 
	Name:
    	 	 
	Title:	 	 

 

	Computershare
    Inc.

    Computershare
    Trust Company N.A.
	 
	 	               	 
	By:	 	 
	Name:
    	 	 
	Title:	 	 

 

    	30

     

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

TO:
TC BIOPHARM (HOLDINGS) PLC

 

(1)
The undersigned hereby elects to purchase ________ Warrant ADSs of the Company pursuant to the terms of the attached Warrant (only if
exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall be in the in lawful money of the United States only.

 

(3)
Please issue said Warrant ADSs in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The
Warrant ADSs shall be delivered to the following DWAC Account Number:

 

_______________________________

_______________________________

_______________________________

 

[SIGNATURE
OF HOLDER]

 

	Name
    of Investing Entity:	 

 

	Signature
    of Authorized Signatory of Investing Entity:	 

 

	Name
    of Authorized Signatory:	 

 

	Title
    of Authorized Signatory:	 

 

	Date:	 

 

    	31

     

    

 

EXHIBIT
B

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 	 
	 	 	(Please
    Print)
	Address:	 	 
	 	 	(Please
    Print)
	Phone
    Number	 	 
	Email
    Address	 	 
	 	 	 
	Dated:
    ______________ ___, _______	 	 
	Holder’s
    Signature:	 	 
	Holder’s
    Address:	 	 

 

    	32

     

    

 

ANNEX
B

 

Form
of Warrant Certificate Request Notice

 

WARRANT
CERTIFICATE REQUEST NOTICE

 

To:
Computershare Inc., as Warrant Agent for TC BioPharm (Holdings) plc (the “Company”)

 

The
undersigned Holder of Purchase Warrants (“Warrants”) in the form of Global Warrants issued by the Company hereby elects
to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:

 

	1.	Name
    of Holder of Warrants in form of Global Warrants:	 
	 	 	 
	2.	Name
    of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants):	 
	 	 	 
	3.	Number
    of Warrants in name of Holder in form of Global Warrants:	 
	 	 	 
	4.	Number
    of Warrants for which Warrant Certificate shall be issued:	 
	 	 	 
	5.	Number
    of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate, if any:	 
	 	 	 
	6.	Warrant
    Certificate shall be delivered to the following address:	 

______________________________

______________________________

______________________________

______________________________

 

The
undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate,
the Holder is deemed to have surrendered the number of Warrants in form of Global Warrants in the name of the Holder equal to the number
of Warrants evidenced by the Warrant Certificate.

 

[SIGNATURE
OF HOLDER]

 

	Name
    of Investing Entity:	 

 

	Signature
    of Authorized Signatory of Investing Entity:	 

 

	Name
    of Authorized Signatory:	 

 

	Title
    of Authorized Signatory:	 

 

	Date:	 

 

    	33

     

    

 

ANNEX
C

 

Form
of Global Warrants Request Notice

 

GLOBAL
WARRANTS REQUEST NOTICE

 

To:
Computershare Inc., as Warrant Agent for TC BioPharm (Holdings) plc (the “Company”)

 

The
undersigned Holder of Purchase Warrants (“Warrants”) in the form of Warrants Certificates issued by the Company hereby
elects to receive a Global Warrant evidencing the Warrants held by the Holder as specified below:

 

	1.	Name
    of Holder of Warrants in form of Warrant Certificates:	 
	 	 	 
	2.	Name
    of Holder in Global Warrant (if different from name of Holder of Warrants in form of Warrant Certificates):	 
	 	 	 
	3.	Number
    of Warrants in name of Holder in form of Warrant Certificates:	 
	 	 	 
	4.	Number
    of Warrants for which Global Warrant shall be issued:	 
	 	 	 
	5.	Number
    of Warrants in name of Holder in form of Warrant Certificates after issuance of Global Warrant, if any:	 
	 	 	 
	6.	Global
    Warrant shall be delivered to the following address:	 

______________________________

______________________________

______________________________

______________________________

 

The
undersigned hereby acknowledges and agrees that, in connection with this Global Warrant Exchange and the issuance of the Global Warrant,
the Holder is deemed to have surrendered the number of Warrants in form of Warrant Certificates in the name of the Holder equal to the
number of Warrants evidenced by the Global Warrant.

 

[SIGNATURE
OF HOLDER]

 

	Name
    of Investing Entity:	 

 

	Signature
    of Authorized Signatory of Investing Entity:	 

 

	Name
    of Authorized Signatory:	 

 

	Title
    of Authorized Signatory:	 

 

	Date:	 

 

    	34Exhibit
10.8

 

Regular
Shareholders Holding Less than 1% (12/11)

 

__________,
2021

 

EF
Hutton,

division
of Benchmark Investments, LLC

as
Representative of the several Underwriters named on Schedule 1 attached hereto

590
Madison Avenue, 39th Floor

New
York, New York 10022

 

Re:
TC BioPharm (Holdings) Limited – Public Offering

 

Ladies
and Gentlemen:

 

The
undersigned holder of ordinary shares, par value £0.01 per share (“Ordinary Shares”), or rights to acquire Ordinary
Shares through American Depositary Shares and warrants to purchase Ordinary Shares or American Depositary Shares (“Investor Warrants”)
of TC BioPharm (Holdings) Limited, a private company limited by shares organized under the law of Scotland, United Kingdom (the “Company”),
understands that you are the representative (the “Representative”) of the several underwriters, if any (collectively,
the “Underwriters”), named or to be named in the final form of Schedule I to the underwriting agreement (the “Underwriting
Agreement”) to be entered into by the several Underwriters and the Company, providing for the public offering of Ordinary Shares
through American depositary Shares and Investor Warrants (the “Public Offering”) registered with the U.S. Securities
and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended. Capitalized terms used herein and
not otherwise defined shall have the meanings set forth in the Underwriting Agreement.

 

For
purposes of this Agreement, references to (a) “Company” shall include TC BioPharm (Holdings) plc, a public limited company
organized or to be organised under the law of Scotland, United Kingdom that will succeed to the interests of the Company pursuant to
a reorganization prior to the closing of the Public Offering and that will be the issuer of the Ordinary Shares and Investor Warrants
in the Public Offering, (b) “Ordinary Shares” shall include the ordinary shares of TC BioPharm (Holdings) plc and American
Depositary Shares representing the Ordinary Shares, and (c) “Investor Warrants” shall include the warrant securities, the
underlying Ordinary Shares and the American Depositary Shares into which the underlying Ordinary Shares may be dematerialized.

 

In
consideration of the Underwriters’ agreement to enter into the Underwriting Agreement and to proceed with the Public Offering,
and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned hereby agrees,
for the benefit of the Company, the Representative and the other Underwriters that, without the prior written consent of the Representative,
the undersigned will not, during the period specified in the following paragraph (the “Lock-Up Period”), directly
or indirectly, unless otherwise provided herein, (a) offer, sell, agree to offer or sell, solicit offers to purchase, grant any call
option or purchase any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of (each a “Transfer”)
any Relevant Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any “put
equivalent position” or liquidate or decrease any “call equivalent position” with respect to any Relevant Security
(in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations thereunder) with respect to any Relevant Security or otherwise enter into any swap, derivative or other
transaction or arrangement that Transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security,
whether or not such transaction is to be settled by the delivery of Relevant Securities, other securities, cash or other consideration,
or otherwise publicly disclose the intention to do so. As used herein, the term “Relevant Security” means Ordinary
Shares, Investor Warrants, any warrant to purchase Ordinary Shares or any other security of the Company or any other entity that is convertible
into, or exercisable or exchangeable for, Ordinary Shares or any other equity or equity linked security of the Company, including any
American Depositary Shares representing the foregoing, in each case owned beneficially or otherwise by the undersigned on the date of
closing of the Public Offering or acquired by the undersigned during the Lock-Up Period; provided however, a Relevant Security does not
include any Ordinary Shares, including American Depositary shares representing the foregoing that is acquired as a result of any equity
award under any equity plan of the Company for the benefit of directors, officers or consultants.

 

    	 

     

    

 

The
restrictions in the foregoing paragraph shall not apply to (a) the exercise (including a cashless exercise or broker-assisted exercise
and payment of tax obligations) of options or warrants to purchase Shares, (b) any establishment of a trading plan pursuant to Rule 10b5-1
under the Exchange Act for the transfer of Shares (a “Trading Plan”), provided that (i) the Trading Plan shall not
provide for or permit any transfers, sales or other dispositions of Shares during the Lock-Up Period and (ii) the Trading Plan would
not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made, or (c) any transfer of Ordinary
Shares acquired in open market transactions following the closing of the Public Offering, provided the transfer would not require any
filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made. The Lock-Up Period will commence on the date
of this Agreement and continue and include the date that is one-hundred eighty (180) days after the closing of the Public Offering.

 

This
Agreement will terminate once the closing price of the Ordinary Shares or American Depositary Shares on the Nasdaq Global Market or such
other national securities exchange on which the Company may from time to time list its Ordinary Shares or American Depositary Shares
as reported by the Nasdaq Stock Market or other reputable and customary source of closing share prices equals or exceeds 300% of the
initial public offering price per Ordinary Share or American Depositary Share in the Public Offering for fifteen consecutive trading
sessions on such exchange.

 

In
addition, the undersigned further agrees that during the Lock-Up Period the undersigned will not, without the prior written consent of
the Representative: (a) other than in respect of a Form S-8 registration statement, file or participate in the filing with the SEC of
any registration statement or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure
document, in each case with respect to any proposed offering or sale of a Relevant Security beneficially owned by the undersigned, or
(b) exercise any rights the undersigned may have to require registration with the SEC of any proposed offering or sale of a Relevant
Security beneficially owned by the undersigned.

 

In
furtherance of the undersigned’s obligations hereunder, the undersigned hereby authorizes the Company during the Lock-Up Period
to cause any transfer agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on the stock register
and other records relating to, Relevant Securities for which the undersigned is the record owner and the transfer of which would be a
violation of this Agreement and, in the case of Relevant Securities for which the undersigned is the beneficial but not the record owner,
agrees that during the Lock-Up Period it will use its reasonable best efforts to cause the record owner to authorize the Company to cause
the relevant transfer agent to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating
to, such Relevant Securities to the extent such transfer would be a violation of this Agreement.

 

Notwithstanding
the foregoing, the undersigned may transfer the undersigned’s Relevant Securities:

 

	 	(i)	as
    a bona fide gift or gifts;
	 	 	 
	 	(ii)	to
    any trust, partnership, limited liability company or other legal entity commonly used for estate planning purposes which is established
    for the direct or indirect benefit of the undersigned or a member or members of the immediate family of the undersigned;

 

    	 

     

    

 

	 	(iii)	if
    the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1) to another corporation,
    partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule
    405 under the Securities Act of 1933, as amended) of the undersigned, (2) to limited partners, limited liability company members
    or stockholders of the undersigned or holders of similar equity interests in the undersigned, or (3) in connection with a sale, merger
    or transfer of all or substantially all of the assets of the undersigned or any other change of control of the undersigned, not undertaken
    for the purpose of avoiding the restrictions imposed by this Agreement;
	 	 	 
	 	(iv)	if
    the undersigned is a trust, to the beneficiary of such trust;
	 	 	 
	 	(v)	by
    testate or intestate succession;
	 	 	 
	 	(vi)	by
    operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement;
	 	 	 
	 	(vii)	pursuant
    to the Underwriting Agreement; or
	 	 	 
	 	(viii)	to
    the Company, it the Company agrees, solely in an amount necessary to satisfy tax obligations (withholding or otherwise) in connection
    with any grant of restricted Ordinary Shares, exercise or vesting of options or warrants to purchase Ordinary Shares, 

 

provided,
however, in the case of clauses (i)-(vi), that (A) such transfer shall not involve a disposition for value, (B) the transferee agrees
in writing with the Underwriters and the Company to be bound by the terms of this Agreement, and (C) such transfer would not require
any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made.

 

For
purposes of this Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote
than first cousin.

 

The
undersigned hereby represents and warrants that (a) the undersigned has full power and authority to enter into this Agreement, (b) this
Agreement has been duly authorized (if the undersigned is not a natural person) or, in the case of a natural person, such person has
the legal capacity to enter into this Agreement, and (c) this Agreement constitutes the legal, valid and binding obligation of the undersigned,
enforceable against the undersigned in accordance with its terms. Upon request, the undersigned will execute any additional documents
necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the successors and assigns
of the undersigned from the date of this Agreement.

 

The
undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the
provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to
be sold thereunder, the undersigned shall be released from all obligations under this Agreement.

 

The
undersigned, whether or not participating in the Public Offering, understands that the Underwriters are entering into the Underwriting
Agreement and proceeding with the Public Offering in reliance upon this Agreement.

 

This
Agreement shall be governed by and construed in accordance with the law of the State of New York. Delivery of a signed copy of this Agreement
by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.

 

	 	Very
    truly yours, 
	 	 	 
	 	Signature:	 
	 	 	 
	 	Name
    (printed):	 
	 	 	 
	 	Title
    (if applicable):	 
	 	 	 
	 	Entity
    (if applicable):

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]